Clinical trials
Phase 2 Hepatorenal Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anna Cruceta | 1 |
| Cumberland Pharmaceuticals | 1 |
| Hospital Clinic of Barcelona | 1 |
| Noorik Biopharmaceuticals AG | 1 |
| Ocelot Bio, Inc | 1 |
| River 2 Renal Corp. | 1 |
| University of California, Los Angeles | 1 |
| University of Turin, Italy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatorenal Syndrome | 8 |
| Fibrosis | 5 |
| Acute Kidney Injury | 4 |
| Renal Insufficiency | 3 |
| Ascites | 2 |
| Adrenal Insufficiency | 1 |
| Hypertension, Portal | 1 |
| Liver Cirrhosis | 1 |
Trials
Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.